Evidence map›Paper›PMID 31386214›Full record

ArticleAlcoholism, clinical and experimental research2019

Effects of Alcohol and Acetate on Cerebral Blood Flow: A Pilot Study.

Jody Tanabe, Dorothy J Yamamoto, Brianne Sutton, Mark S Brown, Paula L Hoffman, Ellen L Burnham, Deborah H Glueck, Boris Tabakoff

Registry-linked trialAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02542150 (Effects of Acetate and Alcohol on Brain Function), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02542150 nacompletednot on this map

Effects of Acetate and Alcohol on Brain Function

TypeinterventionalSponsorUniversity of Colorado, DenverRan2015 to 2017Enrolled24ConditionsCerebral Blood Flow, Brain FunctionArmsacetate, alcohol
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jody TanabeFrom the, Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0002-7110-8444
Dorothy J YamamotoFrom the, Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Brianne SuttonFrom the, Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Mark S BrownFrom the, Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Paula L HoffmanDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Ellen L BurnhamDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Deborah H GlueckDepartment of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Boris TabakoffDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0001-5132-5030
University of Colorado Anschutz Medical Campus · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
The Heritable Transcriptome and AlcoholismR24AA013162 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI HOFFMAN, PAULA, SABA, LAURA MAREN · 2001 to 2021
$14.2M
Supplement: CoPARC: Colorado Pulmonary Alcohol Research CollaborativeR24AA019661 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI ELLEN L BURNHAM · 2011 to 2026
$8.5M
Nezavist a Novel Molecule for Treatment of Alcohol Use DisorderU44AA024905 · NIAAA · LOHOCLA RESEARCH CORPORATION · PI TABAKOFF, BORIS · 2015 to 2021
$7.7M
A novel therapeutic to ameliorate chronic pain and reduce opiate useUG3DA047680 · NIDA · LOHOCLA RESEARCH CORPORATION · PI TABAKOFF, BORIS · 2019 to 2020
$5.7M
BEHAVIORAL PHARMACOGENETICS OF DRUG AND ALCOHOL ABUSET32AA007464 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI HOFFMAN, PAULA · 1987 to 2017
$4.8M
TIM Project NIDA P30 CenterP30DA044223 · NIDA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI WILLIAMS, ROBERT W. · 2017 to 2021
$3.9M
Methods and Software for Lifecourse Epidemiology Data and Sample Size AnalysisR01GM121081 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DABELEA, DANA, GLUECK, DEBORAH HELEN · 2016 to 2019
$2.6M
A Master Course on Power for Multilevel and Longitudinal Health Behavior StudiesR25GM111901 · NIGMS · UNIVERSITY OF FLORIDA · PI GLUECK, DEBORAH HELEN, MULLER, KEITH E · 2014 to 2018
$1.0M
NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR002535NIAAA NIH HHS R24 AA013162NIAAA NIH HHS R24 AA019661NIAAA NIH HHS T32 AA007464NIAAA NIH HHS U44 AA024905NIDA NIH HHS P30 DA044223NIDA NIH HHS UG3 DA047680NIGMS NIH HHS R01 GM121081NIGMS NIH HHS R25 GM111901
6 · The paper itself

Abstract

backgroundAcute alcohol produces effects on cerebral metabolism and blood flow. Alcohol is converted to acetate, which serves as a source of energy for the brain and is an agonist at G protein-coupled receptors distributed in different cell types in the body including neurons. Acetate has been hypothesized to play a role in the cerebral blood flow (CBF) response after alcohol ingestion. We tested whether administration of acetate would alter CBF in a pattern similar to or different from that of alcohol ingestion in healthy individuals.

methodsTwenty-four healthy participants were assigned by convenience to receive either 0.6 g/kg alcohol orally (n = 12) or acetate intravenously (n = 12). For each participant, CBF maps were acquired using an arterial spin labeling sequence on a 3T magnetic resonance scanner after placebo and after drug administration. Whole-brain CBF maps were compared between placebo and drug using a paired t-test, and set at a threshold of p < 0.05 corrected for multiple comparisons (k ≥ 142 voxels, ≥3.78 cm

resultsCompared to placebo, alcohol and acetate were associated with increased CBF in the medial thalamus. Alcohol, but not acetate, was associated with increased CBF in the right orbitofrontal, medial prefrontal and cingulate cortex, and hippocampus. Plasma acetate levels increased following administration of alcohol and acetate and did not differ between the 2 arms. Alcohol, but not acetate, was associated with an increase in SHAS-7 scores (p < 0.001).

conclusionsIncreased thalamic CBF associated with either alcohol or acetate administration suggests that the thalamic CBF response after alcohol could be mediated by acetate. Compared to other brain regions, thalamus may differ in its ability to metabolize acetate or expression of receptors responsive to acetate. Increased prefrontal and limbic CBF associated with alcohol may be linked to alcohol's behavioral effects.

Indexed as

AcetatesAdministration, IntravenousAdministration, OralAdultAlcohol DrinkingBrainCentral Nervous System DepressantsCerebrovascular CirculationEthanolFemaleHumansMagnetic Resonance ImagingMalePilot ProjectsThalamusYoung AdultAcetatesCentral Nervous System DepressantsEthanolAcetateAlcoholCerebral Blood FlowThalamus

Identifiers

PMID31386214
PMCPMC7066986
OpenAlexW2965568542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.